US biotech Amgen is planning to spend $550 million on building a new biologics manufacturing plant in Holly Springs, Wake County in North Carolina. Construction is...
Finnish nanoparticle medicine specialist Nanoform and German drugmaker Boehringer Ingelheim have agreed to collaborate on proof-of-concept studies related to Nanoform’s...
With changes made to the age group of people receiving the AstraZeneca Covid-19 vaccine, the rare but troubling incidence of blood clots seen earlier this year has...
GC International and Cargill, the parent companies of biopolymer producer NatureWorks, have given their final approval for construction of a new Ingeo polylactic acid...
Diversey Holdings, a US-headquartered provider of hygiene, infection prevention and cleaning products, has entered into an agreement to buy Australia’s Tasman Chemicals...
As it continues to grapple with documentation issues, US biotech Novavax has again altered its timeline for seeking Emergency Use Authorization (EUA) from the US Food and...
BP has agreed Memoranda of Understanding (MoUs) with four new potential customers for its proposed clean hydrogen production facility in Teesside, said to be the UK’s...
WuXi STA, CDMO subsidiary of WuXi AppTec, has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland, from US pharma Bristol Myers...
Pfizer and BioNTech applied to the US Food and Drug Administration (FDA) in May for full authorization of their Covid-19 vaccine Comirnaty, and in the interest of...
US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester...
